Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma
Clinical trial NCT07209410 · RECRUITING
Trial details
- NCT number
- NCT07209410
- Sponsor
- Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2026-12-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.